Simulations Plus Stock News

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus releases ADMET Predictor 10.3 (APX.3) with key upgrades to its AIDD Module making it the premier program for AI-driven drug design.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will be presenting at BofA Securities Tech Solutions for Drug Discovery and Oppenheimer Fall Healthcare Life Sciences conferences.

Simulations Plus's total return overperformed the Dow average for my 67-month test period by 308.05%, which is great, and the recent dip is a buying opportunity. Simulations Plus's three-year past CAG

Shares of Simulations Plus are currently attractively priced for long term, growth oriented investors. With zero debt, growing earnings and close to $120 million of cash in the bank, the company's fin

Investors weren't happy about hiccups that pressured fiscal third-quarter revenue.

Simulations Plus, Inc. (SLP) CEO Shawn O'Connor on Q3 2021 Results - Earnings Call Transcript

Shares of Simulations Plus (NASDAQ:SLP) rose fell in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 10.00% year over year to $0.18, which were in

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus reported financial results for the 3rd quarter of FY21. Total revenue increased 4% to $12.8 million with software revenue up by 21%.

Simulations Plus (SLP) fiscal third-quarter performance is likely to reflect gains from strength in its diversified portfolio that includes offerings like GastroPlus, DDDPlus and PKPlus.

On Monday, July 12, Simulations Plus (NASDAQ:SLP) will release its latest earnings report. Decipher the announcement with Benzinga's help.

Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that it will report its 3rd quarter fiscal year 2021 results on Monday, July 12, 2021, with a webcast at 1:15 pm ET.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO Shawn O'Connor will participate in Craig-Hallum's 18th Annual Institutional Investor Conference on June 2, 2021.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that the US FDA renewed its licensing to the DILIsym Services division's flagship QST software platform, DILIsym.

Simulations Plus: Growth Speculation In The Drug Industry